PEOPLE - Cypress Bioscience (US) makes appointment:
This article was originally published in Clinica
Executive Summary
Martin Keller has joined the board of Cypress Bioscience (San Diego, California), a company that develops agents for the diagnosis and treatment of rheumatologic and blood platelet disorders. A psychiatric illness specialist, Dr Keller is currently chairman of the department of psychiatry and human behaviour at the Brown University School of Medicine, in Providence, Rhode Island. At Cypress, he will additionally join the newly formed psychopharmacology advisory board, focusing on developing tests and therapies for fibromyalgia syndrome.